HIV and drug resistance Simon Collins UK-CAB 1 May 2009

Similar documents
HIV drug resistance: a guide for treatment advocates

Antiretroviral Prophylaxis and HIV Drug Resistance. John Mellors University of Pittsburgh

L I F E S C I E N C E S

Fayth K. Yoshimura, Ph.D. September 7, of 7 HIV - BASIC PROPERTIES

HIV Drug Resistance. Together, we can change the course of the HIV epidemic one woman at a time.

HIV INFECTION: An Overview

HIV replication and selection of resistance: basic principles

Building complexity Unit 04 Population Dynamics

Micropathology Ltd. University of Warwick Science Park, Venture Centre, Sir William Lyons Road, Coventry CV4 7EZ

Citation for published version (APA): Von Eije, K. J. (2009). RNAi based gene therapy for HIV-1, from bench to bedside

LESSON 4.4 WORKBOOK. How viruses make us sick: Viral Replication

Section 6. Junaid Malek, M.D.

Viral Vectors In The Research Laboratory: Just How Safe Are They? Dawn P. Wooley, Ph.D., SM(NRM), RBP, CBSP

2 I. Perpetual Molecular Warfare: Viral Evolution in HIV

LESSON 4.6 WORKBOOK. Designing an antiviral drug The challenge of HIV

Human Immunodeficiency Virus

Viral Genetics. BIT 220 Chapter 16

Overview: Chapter 19 Viruses: A Borrowed Life

HIV & AIDS: Overview

How HIV Causes Disease Prof. Bruce D. Walker

Management of patients with antiretroviral treatment failure: guidelines comparison

Fayth K. Yoshimura, Ph.D. September 7, of 7 RETROVIRUSES. 2. HTLV-II causes hairy T-cell leukemia

Chapter 19: Viruses. 1. Viral Structure & Reproduction. 2. Bacteriophages. 3. Animal Viruses. 4. Viroids & Prions

Lecture 2: Virology. I. Background

Retroviruses. ---The name retrovirus comes from the enzyme, reverse transcriptase.

Julianne Edwards. Retroviruses. Spring 2010

Under the Radar Screen: How Bugs Trick Our Immune Defenses

Viral reproductive cycle

HIV/AIDS. Biology of HIV. Research Feature. Related Links. See Also

Fig. 1: Schematic diagram of basic structure of HIV

Introduction retroposon

Rama Nada. - Malik

Last time we talked about the few steps in viral replication cycle and the un-coating stage:

7.014 Problem Set 7 Solutions

Management of NRTI Resistance

HIV-1 Subtypes: An Overview. Anna Maria Geretti Royal Free Hospital

Chapter 19: Viruses. 1. Viral Structure & Reproduction. What exactly is a Virus? 11/7/ Viral Structure & Reproduction. 2.

Section 9. Junaid Malek, M.D.

Introduction to the Impact of Resistance in Hepatitis C

19 Viruses BIOLOGY. Outline. Structural Features and Characteristics. The Good the Bad and the Ugly. Structural Features and Characteristics

HIV Immunopathogenesis. Modeling the Immune System May 2, 2007

Case Study. Dr Sarah Sasson Immunopathology Registrar. HIV, Immunology and Infectious Diseases Department and SydPath, St Vincent's Hospital.

2.1 VIRUSES. 2.1 Learning Goals

11/15/2011. Outline. Structural Features and Characteristics. The Good the Bad and the Ugly. Viral Genomes. Structural Features and Characteristics

Human Immunodeficiency Virus. Acquired Immune Deficiency Syndrome AIDS

Hands-on Activity Viral DNA Integration. Educator Materials

Some living things are made of ONE cell, and are called. Other organisms are composed of many cells, and are called. (SEE PAGE 6)

Evaluation and Management of Virologic Failure

Viruses Tomasz Kordula, Ph.D.

PRINCIPLES and TRENDS in MANAGEMENT of HIV DISEASE: PROBLEMS OF DRUG RESISTANCE in VIRUSES of DIFFERENT SUBTYPES

Lentiviruses: HIV-1 Pathogenesis

7.013 Spring 2005 Problem Set 7

VIRUSES. 1. Describe the structure of a virus by completing the following chart.

For all of the following, you will have to use this website to determine the answers:

2 nd Line Treatment and Resistance. Dr Rohit Talwani & Dr Dave Riedel 12 th June 2012

MedChem 401~ Retroviridae. Retroviridae

Antiviral Drugs Lecture 5

Virus Basics. General Characteristics of Viruses. Chapter 13 & 14. Non-living entities. Can infect organisms of every domain

Resistance Workshop. 3rd European HIV Drug

HIV-1 Dual Infection and Neurocognitive Impairment

History (August 2010) Therapy for Experienced Patients. History (September 2010) History (November 2010) 12/2/11

Virus Basics. General Characteristics of Viruses 5/9/2011. General Characteristics of Viruses. Chapter 13 & 14. Non-living entities

Chapter 13B: Animal Viruses

Introduction to HIV Drug Resistance. Kevin L. Ard, MD, MPH Massachusetts General Hospital Harvard Medical School

Biol115 The Thread of Life"

Revisiting the Definition of Living Thing

Virology Introduction. Definitions. Introduction. Structure of virus. Virus transmission. Classification of virus. DNA Virus. RNA Virus. Treatment.

2I: Disease & Evolution: An Overview

Viruses. Picture from:

Running Head: AN UNDERSTANDING OF HIV- 1, SYMPTOMS, AND TREATMENTS. An Understanding of HIV- 1, Symptoms, and Treatments.

New technologies reaching the clinic

1. Virus 2. Capsid 3. Envelope

Virological failure to Protease inhibitors in Monotherapy is linked to the presence of signature mutations in Gag without changes in HIV-1 replication

Biology 350: Microbial Diversity

Immunologic Methods in Diagnosis of HIV Infection. Tehran Medical Sciences Branch, Islamic Azad

numbe r Done by Corrected by Doctor

Chapter 19: The Genetics of Viruses and Bacteria

5/6/17. Diseases. Disease. Pathogens. Domain Bacteria Characteristics. Bacteria Viruses (including HIV) Pathogens are disease-causing organisms

number Done by Corrected by Doctor Ashraf

Characterizing intra-host influenza virus populations to predict emergence

Antiviral Activity of Tenofovir Alafenamide against HIV-1 with Thymidine Analog Mutation(s) and M184V

Combining Pharmacology and Mutational Dynamics to Understand and Combat Drug Resistance in HIV

Structure of HIV. Virion contains a membrane envelope with a single viral protein= Env protein. Capsid made up of Gag protein

SECTION 25-1 REVIEW STRUCTURE. 1. The diameter of viruses ranges from about a. 1 to 2 nm. b. 20 to 250 nm. c. 1 to 2 µm. d. 20 to 250 µm.

AP Biology Reading Guide. Concept 19.1 A virus consists of a nucleic acid surrounded by a protein coat

Diagnostic Methods of HBV and HDV infections

Size nm m m

Virus and Prokaryotic Gene Regulation - 1

Structure & Function of Viruses

A VACCINE FOR HIV BIOE 301 LECTURE 10 MITALI BANERJEE HAART

Somnuek Sungkanuparph, M.D.

AP Biology. Viral diseases Polio. Chapter 18. Smallpox. Influenza: 1918 epidemic. Emerging viruses. A sense of size

Innovative diagnostics for HIV, HBV and HCV

Viral structure م.م رنا مشعل

Bacteria and Viruses

Panther has new prey

Laboratory diagnostics CH/HIV/0052/17/10/2017

Virion Genome Genes and proteins Viruses and hosts Diseases Distinctive characteristics

Does Resistance Still Matter? Daniel R. Kuritzkes, M.D. Division of Infectious Diseases Brigham and Women s Hospital Harvard Medical School

Transcription:

HIV and drug resistance Simon Collins UK-CAB 1 May 2009 slides: thanks to Prof Clive Loveday, Intl. Clinical Virology Centre www.icvc.org.uk

Tip of the iceberg = HIV result, CD4, VL

Introduction: resistance Drug resistance occurs when treatment is not strong enough to suppress viral replication viral replication is a crucial concept Not just to HIV - ie TB, hepb, herpes, candida ie antibiotics, antivirals, antifungal drugs

Introduction: resistance tests Drug resistance testing has supported therapy of infectious disease for years It has been widely used in bacteriology to guide antibiotic selection In virology its use has been limited by lack of appropriate technologies Two main types: genotypic and phenotypic

Measures Phenotyping (capacity for HIV-1 growth in the presence of individual drugs BIOLOGICAL) Genotyping (sequence changes known to be associated with resistance MOLECULAR)

Definitions & questions What is resistance? How does resistance develop? How can you stop resistance? How is resistance measured? What are the implications of resistance?

Genetics background Genetic material (DNA/RNA) is the chemical package for every living organism: mice, dogs, humans, trees, tomatoes, mould, HIV This is the recipe or code that is used to reproduce more copies ( viral replication ) In humans, the material is in every cell with a nucleus (blood, bone, skin, etc) packaged into blocks called genes, and in humans these genes are collected in chromosomes There are 100 trillion (100,000,000,000,000) cells in the body.

DNA graphic

4 bases: 2 pairs

3 bases = a codon. [= an amino acid]

Understanding Genetics REPLICATION pairs: A-T and C-G A T C A T A T C C G T T A G T A T A G G C A A C T A T C C G T G A A G A T C A T T G T A DNA polymerase A C T T C C G G G A A G G C C T

Understanding Genetics There are 3 billion (3,000,000,000) letters in the DNA code in every cell in your body. Each letter is a base Each group or 3 letters is called a codon, and is a different amino acid. Groups of amino acids form proteins Groups of proteins for genes There are about 30-80,000 genes in humans carrying all the genetic information This is 10% of the total DNA in cells, the other 90% contains non-coding, archived or other DNA By June 26th 2000 scientists understood the rough chemical sequence but only 8000 genes have been identified with a specific role or meaning

Genetics background: HIV Genetic material of HIV (RNA) is the recipe or code use In this virus, this also packaged into genes The full HIV genome is encoded on one long strand of RNA. (In a free virus particle, there are two separate strands of RNA, but they're exactly the same!)this is the form it has when it is a free virus particle. When the virus is integrated into the host's DNA genome (as a provirus) then its information too is encoded in DNA.

Cartoon of HIV gene http://www.mcld.co.uk/hiv

HIV genes gag (coding for the viral capsid proteins) pol (notably, coding for proteins reverse transcriptase, protease, integrase, RNaseH) (NB. gag and pol together can be expressed in one long strand called "gag-pol") env (coding for HIV's envelope-associated proteins) And the regulatory genes: Tat, rev, nef, vif, vpr vpu (N.B. not present in HIV-2) vpx (N.B. not present in HIV-1) http://www.mcld.co.uk/hiv

What is resistance? A change or mutation in the genetic structure of the virus Some mutations have no effect, so may improve the virus and some make it less efficient Some mutations stop a drug from working These effect of these mutations is called resistance

Structure of a virus DNA can REPLICATE (photocopy itself) This is because with the 4 bases: A binds with T and G binds with C. Each group of 3 bases is called an amino acid. There are 21 amino acids - one or two mistakes made by HIV when replicating can change one amino acid to another

Understanding Genetics REPLICATION A T C A T A T C C G T T A G T A T A G G C A A C T A T C C G T G A A G A T C A T T G T A DNA polymerase A C T T C C G G G A A G G C C T

Genetics of HIV (1) 9.2 Kb genome (9200 bases) Genetic material is like a recipe book or code to produce more virus But HIV makes mistakes when reproducing the book (at least 1 base error per replication cycle) Rapid turnover (one generation = 1.5 days) Thus process is a route of HIV EVOLUTION

Genetics of HIV (2) The result of a mutation may be: Neutral (no effect) Disadvantage (poor virus survival) Advantage (improved virus survival)

How does resistance occur? When not on treatment, HIV makes at least one mistake every day But these changes have no reason to keep reproducing because they are usually less fit Resistance only develops when there is ongoing replication (detectable viral load) AND someone is taking drugs

How can you stop resistance? The main way to stop resistance is to be 100% adherent with your meds - this will mean you have the best pharmacology This will minimise your risk of drug levels dropping below the MEC for all 3 drugs If your viral load gets to less than 50 copies/ml, then resistance is very unlikely - because there is not enough HIV replication

Drug levels and resistance The target drug level needs to be above the MEC to avoid resistance and not so high as to cause side effects Increased risk of side effects MEC 0 Increased risk of resistance MEC = Minimum Effective Concentration dose dose dose dose

How is resistance measured? There are two main ways to measure and describe resistance GENOTYPIC resistance looks for changes in the structure of HIV - results as given as specific mutations ie M184V PHENOTYPIC resistance measures how effect a drug in against a sample of virus in a test tube - results as given as fold-changes in a drugs activity

Stanford database http://hivdb.stanford.edu/

Polymerase Reaction (PCR) (Kary Mullis, 1985) Process of automated and specific DNA amplification Possible because of technical/computer advances Allows minute and undetectable quantities of specific microbial DNA to be specifically primed, amplified and biochemically detected Requires a heat-resistant polymerase enzyme A thermal cycler to allow the reaction in one tube in 2 hours

Applications of PCR Diagnostic assays Quantitative viral load assays Resistance assays - phenotyping - genotyping

Evidence - In Vitro (recombinant virus technology) Drug Codon Change Change Sensitivity AZT M41L (ATG-TTG) 4 fold decrease D67N (GAC-AAC) - K70R (AAA-AGA) 8 fold decrease L210W (TTG-TGG) 2 fold decrease T215Y (ACC-TAT) 60-70 fold decrease K219Q (AAA-CAA) 5 fold decrease Combinations 60 + 70 + 215 180 fold decrease 41 + 70 + 215 180 fold decrease 3TC M184V 1000 fold decrease

Evidence - In Vivo Failure of virological suppression is associated with evolving resistance 3TC monotherapy (1992) VL qres 184V Time

What are the implications of resistance? Once you get resistance, it doesn t disappear Resistance can only be detected while you are on treatment Resistance to one drug can be cross-resistant to others in the same family When you stop treatment, those mutations drop to a small minority until eventually they are so rare that the test cannot find them. BUT, when you restart treatment the mutations come back - survival of the fittest!

Drug Resistance & HIV - Background High frequency error-prone replication Allows Darwinian evolution of HIV Specifically in RT and protease genes Process selects viruses day by day with mutations in RT and protease that will function in presence of drugs These viruses are archived and may remain for many years Is an important cause of treatment failure

A Number of Facts Hold True for HIV and Resistance Rapid replication = HIV evolution Evolution obeys Darwinian rules HIV-1 responds rapidly to environmental pressures Single mutations occur daily in untreated patients Double mutations less frequently

slides: thanks to Prof Clive Loveday, Intl. Clinical Virology Centre www.icvc.org.uk

Additional slides

Virtual Phenotype Use sequence data from patient Compare it to a large database of existing sequences with known phenotype (ie biological response to drugs) Derive an estimate of sensitivity to drugs by computer analysis Limitations: Size of comparative database The appearance of new drugs Computer capacity- analysis done as groups and may revert to rules

Guidelines (IAS-USA, Euroguidelines, BHIVA) - PHI -If early Rx local policy then minimum delay. Recommend - modify or real time testing - Chronic -Consider/Recommend - response to 1st (Naïve) therapy is important - 2nd+ Rx - Recommend - Salvage - Recommend Pregnancy - Recommend in mums with detectable VL Paediatrics - Recommend testing babies if Rxed mum - Recommend in kids with failure PEP - Recommend (do not delay Rx)

Clinical Virologist ( Expert ) Report Results are complex New data is continuously becoming available Clinical virologist ( expert ) should review Opinion should be documented Opinion/advice/consultation/discussion should be available to physicians

Evidence - In Vitro Growth of viruses in the presence of drug in multiple rounds of culture result in mutational changes in the RT/ protease genes. The resulting daughter viruses have decreased drug sensitivity Sequencing of these viruses revealed mutation sites in genome

Unresolved Problems Sensitivity of assays Specificity of assays QC/QA Primer/probe fidelity and diverse viruses Applications/role of resistance for clinical management Further evidence with RCT s to define exact role for resistance testing

Understanding Genetics Imagine the human genome as a book: Each paragraph in the stories is made of words called CODONS Each word is written in letters called BASES Groups of words make sentences (proteins) Groups of proteins make paragraphs or stories (30-80,000 genes) Paragraphs are EXONS (10%) - the stories - and each paragraph is interrupted by advertisements called INTRONS (90%) Groups of genes make chromosomes (23 chapters)

Understanding Genetics One billion words in the book, if you read the genome at one word (CODON) per second for 8 hours per day it would take a century. This is a gigantic document, in a microscopic cell. The genome like a book is written in linear, one dimensional and one directional form, and is defined by a code that transliterates a small alphabet of signs into a large lexicon of meanings through their order and grouping

Understanding Genetics The chemistry used 4 letters A,G,C,T. These are chemical bases adenine, guanine, cytosine and thymine and in different sequences they form the code. Almost everything in the body is made of protein or needs proteins to make it Proteins are made of chemicals (building blocks) called amino acids (21) The sequence of these bases in groups of 3 spell out the code for different amino acids Thus a template to build proteins is carried in the DNA

Human chromosomes In humans, each cell normally contains 23 pairs of chromosomes, for a total of 46. 22 of these pairs look the same in both men and women. The 23rd pair, the sex chromosomes, differ between males and females. Women have 2 copies of the X chromosome, while men have one X and one Y chromosome.

Causes of Drug Failure Evolution of drug resistant viruses Pharmacological resistance absorption distribution metabolism activation interactions excretion Adherence to therapy

Basic Needs Collect EDTA blood Store plasma within 6+ hours -70C Viral >1000 c/ml Geographical origin Store blood at every therapeutic crossroads Test at failure or within 2 weeks of stopping Rx